RecruitingNot ApplicableNCT06591286

Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control

Effects of Real-time Continuous Glucose Monitoring System on Hospital-to-home Transitional Blood Glucose Control and Self-efficacy Among Patients With Type 2 Diabetes Treated With Insulin

Sponsor

Shanghai 6th People's Hospital

Enrollment

150 participants

Start Date

Oct 25, 2024

Study Type

INTERVENTIONAL

Conditions

Diabetes Mellitus, Type 2

Summary

Glucose monitoring is an important part of self-management for patients with diabetes. The results of glucose monitoring not only help to assess the degree of glucose metabolism disorders in patients, but also help physicians to make clinical decisions and guide patients in self-management. Despite extensive efforts and advances in diabetes management during hospitalization, glucose control after patients is discharged home remains a challenge. This trial aims to explore the effect of real-time continuous glucose monitoring (RT-CGM) system compared to self-monitoring of blood glucose (SMBG) group on glucose and self-efficacy of type 2 diabetes patients treated with insulin after discharge from the hospital.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether using a real-time continuous glucose monitor (CGM) — a small wearable sensor that tracks blood sugar continuously — helps people with Type 2 diabetes better manage their blood sugar levels after leaving the hospital and transitioning back to home life. **You may be eligible if...** - You are between 18 and 80 years old - You have Type 2 diabetes and were admitted to a hospital endocrinology unit - Your HbA1c is between 8% and 12% - You are on insulin therapy and plan to continue at home after discharge - You currently check your blood sugar fewer than 4 times per week and have never used a CGM system **You may NOT be eligible if...** - You are on oral corticosteroid therapy - You have serious diabetes complications (e.g., ketoacidosis or very high blood sugar emergencies) - You have severe liver disease or severe kidney failure (eGFR below 30) - You have a skin condition or allergy around the sensor site - You are pregnant, breastfeeding, or unwilling to use contraception during the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERT-CGM

This group of patients will wear RT-CGM for blood glucose monitoring for three months.

DEVICESMBG

This group of patients will use a a fingertip glucose meter for blood glucose monitoring for three months, and the monitoring frequency was not less than 4 times per week.